Study,Date,Doses,Ages,Effectiveness,ve_hosp_minus_error,ve_hosp_plus_error
"""Dagan et al., Apr-21""",21-Apr,2 vs 0 Doses (>16yo),>16 years,0.87,0.32,0.13
"Barda et al, Dec-21",21-Dec,3 vs 2 Doses (>12yo),">12, median age 52",0.93,0.05,0.04
"Arbel et al, Apr-22",22-Apr,4 vs 3 Doses (>60yo),60-100,0.64,0.07,0.05
"Magen et al, Apr 22",22-Apr,4 vs 3 Doses (>60yo),>60,0.68,0.09,0.06
"Arbel et al, Jan-23",23-Jan,Bivalent vs 0+ Doses (>65yo),>65 years,0.81,0.24,0.11